Goldman Sachs
SRTA

Goldman Sachs’s Strata Critical Medical Inc SRTA Stock Holding History

Goldman Sachs’s Portfolio SRTA Stock Details SRTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.73M Sell
414,445
-59,079
-12% -$284K ﹤0.01% 4663
2025
Q4 		$2.28M Buy
473,524
+219,730
+87% +$1.06M ﹤0.01% 4462
2025
Q3 		$1.28M Buy
253,794
+56,140
+28% +$248K ﹤0.01% 4856
2025
Q2 		$797K Sell
197,654
-68,760
-26% -$224K ﹤0.01% 4860
2025
Q1 		$727K Sell
266,414
-106,618
-29% -$382K ﹤0.01% 4932
2024
Q4 		$1.59M Sell
373,032
-60,024
-14% -$229K ﹤0.01% 4493
2024
Q3 		$1.27M Sell
433,056
-10,776
-2% -$34.3K ﹤0.01% 4471
2024
Q2 		$1.54M Buy
443,832
+274,984
+163% +$917K ﹤0.01% 4126
2024
Q1 		$481K Sell
168,848
-24,546
-13% -$75.7K ﹤0.01% 4766
2023
Q4 		$683K Buy
193,394
+75,199
+64% +$216K ﹤0.01% 4587
2023
Q3 		$306K Sell
118,195
-1,837,957
-94% -$6.46M ﹤0.01% 4889
2023
Q2 		$7.71M Sell
1,956,152
-637,180
-25% -$2.02M ﹤0.01% 2701
2023
Q1 		$8.77M Buy
2,593,332
+2,502,510
+2,755% +$10.2M ﹤0.01% 2539
2022
Q4 		$325K Buy
90,822
+49,846
+122% +$213K ﹤0.01% 5102
2022
Q3 		$165K Buy
40,976
+28,615
+231% +$147K ﹤0.01% 5544
2022
Q2 		$55K Sell
12,361
-212,063
-94% -$1.53M ﹤0.01% 6011
2022
Q1 		$1.91M Buy
224,424
+35,047
+19% +$246K ﹤0.01% 4309
2021
Q4 		$1.67M Buy
+189,377
New +$1.8M ﹤0.01% 4403
2021
Q1 		– Sell
-23,529
Closed -$261K – 6083
2020
Q4 		$261K Sell
23,529
-51,471
-69% -$525K ﹤0.01% 4954
2020
Q3 		$754K Buy
+75,000
New +$757K ﹤0.01% 4259

Other funds holding SRTA

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
TP
Third Point New York $2.08B AUM 27.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NRCM
Northern Right Capital Management Darien, Connecticut $281M AUM 56.22% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
PLC
Pillsbury Lake Capital San Francisco, California $221M AUM
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Goldman Sachs's SRTA Position: Q1 2026 in Review

Goldman Sachs reduced its Strata Critical Medical Inc (SRTA) stake by 12% in Q1 2026, selling an estimated $284K and leaving 414,445 shares worth $1.73M. The position accounts for ﹤0.01% of the portfolio, ranked #4663.

Goldman Sachs first reported a position in SRTA in Q3 2020 and has held it in 20 quarters since. The position peaked at $8.77M in Q1 2023. 125 funds tracked by Wall St. Rank hold SRTA as of Q1 2026.

  • Goldman Sachs held 414,445 shares of Strata Critical Medical Inc worth $1.73M as of Q1 2026.
  • Goldman Sachs sold 59,079 Strata Critical Medical Inc shares in Q1 2026, an estimated $284K.
  • Strata Critical Medical Inc made up ﹤0.01% of Goldman Sachs's portfolio in Q1 2026, its #4663 holding.
  • Goldman Sachs first reported a position in Strata Critical Medical Inc in Q3 2020 and has held it in 20 quarters since.
  • Goldman Sachs's Strata Critical Medical Inc position peaked at $8.77M in Q1 2023.
  • 125 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.